Multiscalar Information: Developing a Data Analysis Framework for Molecular Analysis of Kidney Diseases

Lessons Learned from Pathology: Integrating Molecular Analysis with Structural Information

Strategy to Safely Obtain Protocol Renal Biopsy in Kidney Diseases in a Multicenter Setting

Patient Engagement in Action

Richard Knight, the current President of the American Association of Kidney Patients (AAKP) and co-chair of our community engagement working group (CEWG), discussing the impact of the CEWG on this project, with an emphasis on the specific influence from our patient representatives.

How Can Precision Medicine Advance Nephrology

Dr. Robert Star, Director, Kidney, Urologic, and Hematologic Diseases at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) spoke about how precision medicine can advance nephrology.

Charting a New Course to Define Chronic and Acute Kidney Diseases

Dr. Krzysztof Kiryluk took the stage to discuss charting a new course to define chronic and acute kidney diseases. He explained some of the problems with the current approaches to define these diseases, reviewed some of the available alternatives, and showed how these approaches informed the development of the KPMP clinical protocol and study design.

A Glimpse of the Future: Precision Kidney Pathology

Dr. Ulysses Balis shows a glimpse of the future, demonstrating how the adoption of digital pathology and the integration of machine learning can influence the development and extend the impact of the KPMP’s kidney tissue atlas.

A Kidney Tissue Atlas to Guide Patients, Providers and Scientists

Dr. Laura Mariani walks the session attendees through several potential uses that are envisioned for the atlas, emphasizing the various functionality needed to support our different user communities – including patients, providers, and researcher scientists.